Smoking promotes subclinical atherosclerosis in apparently healthy men: 2-year ultrasonographic follow-up

Circulation Journal

Volumn 76, Issue 12, 2012, Pages 2884-2891

  Sanada, Shoji ^a,b   Nishida, Makoto ^a,b   Ishii, Kouki ^a   Moriyama, Toshiki ^a   Komuro, Issei ^b   Yamauchi Takihara, Keiko ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Inflammation; Intima media thickness; Metabolic syndrome; Progression; Smoking cessation

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; TRIACYLGLYCEROL;

ADULT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; RISK ASSESSMENT; RISK FACTOR; SMOKING; SMOKING CESSATION; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; ANALYSIS OF VARIANCE; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, LDL; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 84870525836     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1506     Document Type: Article

References (38)

1. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004; 109: III15-III19.
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Defnition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientifc issues related to defnition. Circulation 2004; 109: 433-438.
3. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24: 29-33.
4. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89.
5. Luc G, Bard JM, Juhan-Vague I, Ferrieres J, Evans A, Amouyel P, et al. C-reactive protein, interleukin-6, and fbrinogen as predictors of coronary heart disease: The PRIME Study. Arterioscler Thromb Vasc Biol 2003; 23: 1255-1261.
6. Erhardt L. Cigarette smoking: An undertreated risk factor for cardiovascular disease. Atherosclerosis 2009; 205: 23-32.
7. Nguyen AB, Rohatgi A, Garcia CK, Ayers CR, Das SR, Lakoski SG, et al. Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: The Dallas Heart Study. Arterioscler Thromb Vasc Biol 2011; 31: 2136-2143.
8. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis 2005; 181: 381-388.
9. Peters SA, Grobbee DE, Bots ML. Carotid intima-media thickness: A suitable alternative for cardiovascular risk as outcome? Eur J Car-diovasc Prev Rehabil 2011; 18: 167-174.
10. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: Prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37: 87-92.
11. Blackburn R, Giral P, Bruckert E, André JM, Gonbert S, Bernard M, et al. Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterio-scler Thromb Vasc Biol 2001; 21: 1962-1968.
12. Yasmin, McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004; 24: 969-974.
13. Mahmud A, Feely J. Arterial stiffness is related to systemic infam-mation in essential hypertension. Hypertension 2005; 46: 1118-1122.
14. Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K. Interleu-kin-10 associates with adiponectin predominantly in subjects with metabolic syndrome. Circ J 2007; 71: 1234-1238.
15. Nishida M, Moriyama T, Ishii K, Takashima S, Yoshizaki K, Sugita Y, et al. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis. Clin Chim Acta 2007; 384: 99-104.
16. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, et al; Advisory Board of the 3rd Watching the Risk Symposium 2004, 13th European Stroke Conference. Mannheim in-tima-media thickness consensus. Cerebrovasc Dis 2004; 18: 346-349.
17. Erhardt L. Cigarette smoking: An undertreated risk factor for cardiovascular disease. Atherosclerosis 2009; 205: 23-32.
18. Pipe AL, Papadakis S, Reid RD. The role of smoking cessation in the prevention of coronary artery disease. Curr Atheroscler Rep 2010; 12: 145-150.
19. van den Berkmortel FW, Wollersheim H, van Langen H, Smilde TJ, den Arend J, Thien T. Two years of smoking cessation does not reduce arterial wall thickness and stiffness. Neth J Med 2004; 62: 235-241.
20. Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: Results from the Third National Health and Nutrition Examination Survey. PLoS Med 2005; 2: e160.
21. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, et al. C-reactive protein, a sensitive marker of infammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-242.
22. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, et al. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537.
23. Shah PK. Infammation and plaque vulnerability. Cardiovasc Drugs Ther 2009; 23: 31-40.
24. Jöckel KH, Lehmann N, Jaeger BR, Moebus S, Möhlenkamp S, Schmermund A, et al. Smoking cessation and subclinical atherosclerosis: Results from the Heinz Nixdorf Recall Study. Atherosclerosis 2009; 203: 221-227.
25. Toprak A, Kandavar R, Toprak D, Chen W, Srinivasan S, Xu JH, et al. C-reactive protein is an independent predictor for carotid artery intima-media thickness progression in asymptomatic younger adults (from the Bogalusa Heart Study). BMC Cardiovasc Disord 2011; 11: 78.
26. Liviakis L, Pogue B, Paramsothy P, Bourne A, Gill EA. Carotid in-tima-media thickness for the practicing lipidologist. J Clin Lipidol 2010; 4: 24-35.
27. Oyama J, Maeda T, Kouzuma K, Ochiai R, Tokimitsu I, Higuchi Y, et al. Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers. Circ J 2010; 74: 578-588.
28. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, et al. Metabolic syndrome amplifes the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004; 43: 1388-1395.
29. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis 2005; 181: 381-388.
30. Hata J, Doi Y, Ninomiya T, Fukuhara M, Ikeda F, Mukai N, et al. Combined effects of smoking and hypercholesterolemia on the risk of stroke and coronary heart disease in Japanese: The Hisayama study. Cerebrovasc Dis 2011; 31: 477-484.
31. Liu KH, Chan YL, Chan WB, Chan JC, Chu CW. Mesenteric fat thickness is an independent determinant of metabolic syndrome and iden-tifes subjects with increased carotid intima-media thickness. Diabetes Care 2006; 29: 379-384.
32. Johnsen SH, Mathiesen EB, Fosse E, Joakimsen O, Stensland-Bugge E, Njølstad I, et al. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: A follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study. Circulation 2005; 112: 498-504.
33. Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, et al. The Justifcation for Atherosclerosis Regression Treatment (JART) Investigators. Effect of intensive lipid-lowering therapy with rosuv-astatin on progression of carotid intima-media thickness in Japanese patients. Circ J 2011; 76: 221-229.
34. Matsuzawa Y. Therapy insight: Adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006; 3: 35-42.
35. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med 2006; 16: 141-146.
36. Efstathiou SP, Skeva II, Dimas C, Panagiotou A, Parisi K, Tzanoumis L, et al. Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population. Atherosclerosis 2009; 205: 632-636.
37. Takefuji S, Yatsuya H, Tamakoshi K, Otsuka R, Wada K, Matsushita K, et al. Smoking status and adiponectin in healthy Japanese men and women. Prev Med 2007; 45: 471-475.
38. Cui R, Iso H, Yamagishi K, Tanigawa T, Imano H, Ohira T, et al. Relationship of smoking and smoking cessation with ankle-to-arm blood pressure index in elderly Japanese men. Eur J Cardiovasc Prev Rehabil 2006; 13: 243-248.